NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
---|---|---|---|---|---|
Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of NATH BIOGENES (INDIA) ?
Year | Current Liabilities |
---|---|
Mar2025 | - |
Mar2024 | - |
Mar2023 | - |
Mar2022 | - |
Mar2013 | - |
How is Current Liabilities of NATH BIOGENES (INDIA) Trending?
Years | Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | - | 0 | |
Mar2024 | - | 0 | |
Mar2023 | - | 0 | |
Mar2022 | - | 0 | |
Mar2013 | - | - |
Compare Current Liabilities of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹329.9 Cr | 3.3% | -1.4% | -23.8% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,324.7 Cr | -1.6% | 3.7% | -28.2% | Stock Analytics | |
KAVERI SEED COMPANY | ₹5,929.4 Cr | -3.5% | 0.1% | 10.9% | Stock Analytics | |
VENKYS (INDIA) | ₹2,121.8 Cr | 0.7% | 2% | -32.8% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,362.7 Cr | -3% | -3.8% | -29.8% | Stock Analytics | |
INDO US BIOTECH | ₹283.4 Cr | -2.2% | -6.1% | -56.5% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | 3.3% |
-1.4% |
-23.8% |
SENSEX | 0.5% |
0.4% |
-1.1% |
You may also like the below Video Courses